China Diagnostic Imaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

China Diagnostic Imaging Market Analysis

The China Diagnostic Imaging Market size is estimated at USD 3.18 billion in 2024, and is expected to reach USD 4.27 billion by 2029, growing at a CAGR of 6% during the forecast period (2024-2029).

The market is expected to show healthy growth owing to the growing prevalence of chronic diseases, the growing geriatric population, and the increased adoption of advanced technologies in medical imaging.

China is experiencing a significant increase in chronic diseases such as cardiovascular diseases, diabetes, cancer, and respiratory disorders. This rise is driven by aging populations, lifestyle changes, and environmental factors. For instance, as per an article published in Frontier in Public Health in October 2023, in China, approximately 6.0% of individuals aged 60 and older are estimated to have Alzheimer's disease. Projections indicate that by 2030, the aging demographic could push the number of cases to over 20 million. Additionally, according to the International Diabetes Federation, 164.6 million people are projected to be diagnosed with diabetes, with this number expected to rise to 174.4 million by 2045. Thus, as chronic diseases become more prevalent, there is a heightened demand for early and accurate diagnosis. This drives the need for advanced imaging technologies and will likely support the market expansion during the forecast period.

Also, the government support and strategic initiatives taken in the country that bolster the adoption of diagnostic imaging are likely to spur market growth during the forecast period. For instance, in March 2024, the Chinese government initiated the "One Thousand Counties Project," targeting enhancing healthcare infrastructure in rural regions. The project enhances hospital capabilities by integrating advanced imaging technologies such as CT and MRI scanners. This move aligns with the government's commitment to augment healthcare access for its aging populace. Thus, such initiatives are expected to increase demand for diagnostics imaging in the country, driving market growth.

The introduction of innovative imaging technologies, such as MRI, CT, PET, and ultrasound machines, is transforming the diagnostics landscape in China. Advances in imaging resolution, speed, and functionality make these tools more practical and are expected to propel the market's growth. For instance, in February 2023, Mindray, a China-based developer and provider of advanced medical devices and solutions, launched its first wireless handheld ultrasound system, the TE Air. Additionally, in February 2023, GE Healthcare formed a long-term joint venture with a subsidiary of a Chinese state-owned drugmaker to provide non-premium CT and general imaging ultrasound solutions. Thus, such launches and collaboration are expected to increase the adoption of imaging equipment that can offer a broader range of services, which is anticipated to bolster the market growth.

Thus, the high burden of chronic diseases, supportive government initiatives, and increasing product launches and collaboration initiatives by the industry players are expected to contribute to market growth during the forecast period. However, the high cost associated with devices and the side effects of diagnostic imaging may hamper the development of the market during the forecast period.

China Diagnostic Imaging Industry Trends

The Oncology Segment is Expected to Hold a Major Market Share in the Chinese Diagnostic Imaging Market

China Diagnostic Imaging Industry Segmentation

As per the scope of the report, diagnostic imaging captures images of the internal structure of the human body using electromagnetic radiation for an accurate diagnosis. There are various types of medical imaging, the most common ones being CT scanners, MRI systems, etc.

The Chinese diagnostic imaging market is segmented by modality, application, and end user. By modality, the market is segmented as MRI, computed tomography, ultrasound, X-ray, nuclear imaging, fluoroscopy, and mammography. By MRI, the market is further sub-segmented into low and mid-field MRI systems (less than 1.5 T), high-field MRI systems (1.5-3 T), and very high and ultra-high field MRI systems (3T and more). By computed tomography, the market is further sub-segmented as low-end scanners (~16-slice), mid-range scanners (~64-slice), and high-end scanners (128-slice and more). By ultrasound, the market is further sub-segmented into 2D ultrasound, 3D ultrasound, and other ultrasound. By X-ray, the market is sub-segmented into analog systems and digital systems. By nuclear imaging, the market is sub-segmented into positron emission tomography (PET) and single photon emission computed tomography (SPECT). By application, the market is segmented as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and other applications. By end user, the market is segmented as hospitals, diagnostic centers, and other end users. The report offers the market size and forecasts in value (USD) for the above segments.